Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roopa Sethi

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
The Primary Care Companion for CNS Disorders|January 13, 2023
The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment: A Review of the LiteratureJaya Sri Konakanchi, Roopa Sethi
Substance Abuse|April 2, 2021
Covid19 impact screening of patients undergoing medication treatment for opioid use disorderAnn M Manzardo, Roopa Sethi
The Primary Care Companion for CNS Disorders|June 28, 2018
I Use "Wax" Because It Makes Me Calmer, But Now I Am Seeing 3D ImagesRoopa Sethi, Dominic DiPrinzo, Ryan McAllister
The Primary Care Companion for CNS Disorders|May 21, 2019
Should Long-Acting Depot Intramuscular Naltrexone Be Prescribed Every 3 Weeks for Alcohol Use Disorder?Joel Luvisi, Kyle Ahonen, Roopa Sethi
Journal of Opioid Management|March 27, 2024
Tianeptine as an opiate replacement in a patient on methadone treatment: A case reportVivek Velagapudi, Jordan Calabrese, Roopa Sethi
Journal of Addictive Diseases|January 25, 2024
Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable formVivek Velagapudi, Luke Schuster, Roopa Sethi
The Primary Care Companion for CNS Disorders|September 10, 2020
Should Buprenorphine Induction Dosing Be Lower for the Elderly Population With Opioid Use Disorder? A Case of Buprenorphine-Induced Hemodynamic InstabilityAnnelise Chaparro, Dheepthi Arakonam Ravishankar, Roopa Sethi
Kansas Journal of Medicine|October 23, 2025
Concomitant Tianeptine and Alcohol Use Disorders: Diagnosis and Treatment with Buprenorphine-NaloxoneQuinn Krause, Margaret Lloyd Sieger, Roopa Sethi
Kansas Journal of Medicine|May 2, 2024
The Effectiveness of Buprenorphine Transdermal Patch and Low Dose Sublingual Buprenorphine Induction to Transition to Long-Acting Subcutaneous Buprenorphine Injection in Opioid Use Disorder in Inpatient SettingJack W Gorham, Faisal Ansari, Roopa Sethi
The Primary Care Companion for CNS Disorders|July 24, 2018
Kratom: Is It the New Illicit Opiate on the Market?Roopa Sethi, Kory A Miller, Ryan McAllister
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Primary Care Companion for CNS Disorders|January 13, 2023
The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment: A Review of the LiteratureJaya Sri Konakanchi, Roopa Sethi
Substance Abuse|April 2, 2021
Covid19 impact screening of patients undergoing medication treatment for opioid use disorderAnn M Manzardo, Roopa Sethi
The Primary Care Companion for CNS Disorders|June 28, 2018
I Use "Wax" Because It Makes Me Calmer, But Now I Am Seeing 3D ImagesRoopa Sethi, Dominic DiPrinzo, Ryan McAllister
The Primary Care Companion for CNS Disorders|May 21, 2019
Should Long-Acting Depot Intramuscular Naltrexone Be Prescribed Every 3 Weeks for Alcohol Use Disorder?Joel Luvisi, Kyle Ahonen, Roopa Sethi
Journal of Opioid Management|March 27, 2024
Tianeptine as an opiate replacement in a patient on methadone treatment: A case reportVivek Velagapudi, Jordan Calabrese, Roopa Sethi
Journal of Addictive Diseases|January 25, 2024
Buprenorphine: two adolescent case reports of bridging the transmucosal form to the extended-release subcutaneous injectable formVivek Velagapudi, Luke Schuster, Roopa Sethi
The Primary Care Companion for CNS Disorders|September 10, 2020
Should Buprenorphine Induction Dosing Be Lower for the Elderly Population With Opioid Use Disorder? A Case of Buprenorphine-Induced Hemodynamic InstabilityAnnelise Chaparro, Dheepthi Arakonam Ravishankar, Roopa Sethi
Kansas Journal of Medicine|October 23, 2025
Concomitant Tianeptine and Alcohol Use Disorders: Diagnosis and Treatment with Buprenorphine-NaloxoneQuinn Krause, Margaret Lloyd Sieger, Roopa Sethi
Kansas Journal of Medicine|May 2, 2024
The Effectiveness of Buprenorphine Transdermal Patch and Low Dose Sublingual Buprenorphine Induction to Transition to Long-Acting Subcutaneous Buprenorphine Injection in Opioid Use Disorder in Inpatient SettingJack W Gorham, Faisal Ansari, Roopa Sethi
The Primary Care Companion for CNS Disorders|July 24, 2018
Kratom: Is It the New Illicit Opiate on the Market?Roopa Sethi, Kory A Miller, Ryan McAllister
Pageof 5